Lucia Musacchio

Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial

Sandro Pignata, Giovanni Scambia, Clorinda Schettino et al. · The Lancet Oncology · 2023 · 46 citations

Medicine, Cancer Management, Mito End-3 +7

Adnexal masses in pregnancy: an updated review on diagnosis and treatment

Valentina D’Ambrosio, Roberto Brunelli, Lucia Musacchio et al. · Tumori Journal · 2020 · 35 citations

Incorporation of anti-PD1 or anti PD-L1 agents to platinum-based chemotherapy for the primary treatment of advanced or recurrent endometrial cancer. A meta-analysis

Michele Bartoletti, Marcella Montico, Domenica Lorusso et al. · Cancer Treatment Reviews · 2024 · 31 citations · Full text

PD-L1 expression is associated with tumor infiltrating lymphocytes that predict response to NACT in squamous cell cervical cancer

Nicoletta D’Alessandris, Innocenza Palaia, Angelina Pernazza et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2020 · 27 citations

Cancer Immunosurveillance, Cervical Cancer, Pd-l1 Expression +7

Clinical characteristics and molecular aspects of low-grade serous ovarian and peritoneal cancer: a multicenter, observational, retrospective analysis of MITO Group (MITO 22)

Lucia Musacchio, Daniela Califano, Michele Bartoletti et al. · British Journal of Cancer · 2022 · 25 citations · Full text

Tumoral Pathology, Medicine, Mito 22 +8